Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Fuji
Harvard Business School
Express Scripts
McKesson
US Army
UBS
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

SULFAPYRIDINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Sulfapyridine patents expire, and what generic alternatives are available?

Sulfapyridine is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in SULFAPYRIDINE is sulfapyridine. There are seven drug master file entries for this compound. Additional details are available on the sulfapyridine profile page.
Summary for SULFAPYRIDINE
Drug patent expirations by year for SULFAPYRIDINE
Medical Subject Heading (MeSH) Categories for SULFAPYRIDINE
Synonyms for SULFAPYRIDINE
[(4-aminophenyl)sulfonyl]-2-pyridylamine
144-83-2
2-(4-Aminobenzenesulfonamido)pyridine
2-(p-Aminobenzenesulfonamido)pyridine
2-(p-Aminobenzenesulphonamido)pyridine
2-Sulfanilamidopyridin
2-Sulfanilamidopyridin [German]
2-Sulfanilamidopyridine
2-Sulfanilyl aminopyridine
2-Sulfanilylaminopyridine
2-Sulfapyridine
4-(2-Pyridinylsulfonyl)aniline
4-(2-Pyridinylsulfonyl)aniline #
4-[(2-Pyridylamino)sulfonyl]aniline
4-amino-n-(2-pyridinyl)benzenesulfonamide
4-amino-N-(2-pyridyl)benzenesulfonamide
4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide
4-amino-N-(pyridin-2-yl)benzenesulfonamide
4-Amino-N-[2-pyridyl]benzene sulfonamide
4-Amino-N-2-pyridinyl- benzenesulfonamide
4-Amino-n-2-pyridinyl-benzenesulfonamide
4-AMINO-N-2-PYRIDINYLBENZENESULFONAMIDE
4-amino-N-pyridin-2-yl-benzenesulfonamide
4-amino-N-pyridin-2-ylbenzenesulfonamide
4-Amino-N,2-pyridinylbenzenesulfonamide
4-azanyl-N-pyridin-2-yl-benzenesulfonamide
A-499
A808279
AB00052100
AB00052100_14
AB00052100_15
AB2000164
AC-26818
AC1L1K4N
AC1Q51XL
Adiplon
AI3-01049
AK400564
AKOS000121424
ALBB-006215
AN-43961
ANW-43071
AO-801/41077453
BB 0258406
BBL007713
BDBM39340
Benzenesulfonamide, 4-amino-N-(2-pyridinyl)-
Benzenesulfonamide, 4-amino-N-2-pyridinyl-
BPBio1_000886
BRD-K41406082-001-05-5
BSPBio_000804
BSPBio_003265
C11H11N3O2S
CAS-144-83-2
CCG-39261
CHEBI:132842
CHEMBL700
cid_5336
Coccoclase
Coccoclase;Eubasin;Eubasinum;Haptocil;Dagenan
CS-2157
CTK3J2133
D02434
D0D4CY
Dagenan
DB-042750
DB00891
DivK1c_000216
DSSTox_CID_6067
DSSTox_GSID_26067
DSSTox_RID_78003
DTXSID3026067
EINECS 205-642-7
Epitope ID:122235
Eubasin
Eubasinum
FT-0631839
GECHUMIMRBOMGK-UHFFFAOYSA-
GECHUMIMRBOMGK-UHFFFAOYSA-N
H460
Haptocil
HE003686
HE311828
HE311829
HMS1570I06
HMS1921C03
HMS2092K05
HMS2097I06
HMS2233H20
HMS3372N13
HMS500K18
HS-0063
HY-B0212
I14-1461
IDI1_000216
InChI=1/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
J10161
KBio1_000216
KBio2_001476
KBio2_004044
KBio2_006612
KBio3_002766
KBioGR_000751
KBioSS_001476
KS-00000G93
LS-854
M + B 693
M and B 693
M&B 693
M&B-693
M+B 693
MCULE-7911106459
MFCD00038036
MLS000069725
MolPort-000-883-306
N-2-Pyridylsulfanilamide
N'-2-Pyridylsulfanilide
N(1)-2-Pyridylsulfanilamide
N(1)-Pyridylsulfanilamide
N(sup 1)-2-Pyridylsulfanilamide
N(sup1)-Pyridylsulfanilamide
N1-(Pyridin-2-yl)sulfanilamide
N1-2-Pyridylsulfanilamide
N1-Pyridylsulfanilamide
NCGC00016408-01
NCGC00016408-02
NCGC00016408-03
NCGC00016408-04
NCGC00016408-05
NCGC00016408-06
NCGC00016408-09
NCGC00016408-10
NCGC00022008-03
NCGC00022008-04
NINDS_000216
NSC 41791
NSC 4753
NSC-41791
NSC-4753
NSC-757329
NSC41791
NSC4753
NSC757329
Oprea1_344996
Pharmakon1600-01500551
Piridazol
pirodazole
Plurazol
Prestwick_1015
Prestwick0_000762
Prestwick1_000762
Prestwick2_000762
Prestwick3_000762
Pyriamid
Pyridazol
R1664
Relbapiridina
Ronin
RTR-005667
S0071
s1617
SBB003154
SBI-0051525.P003
SC-65296
SCHEMBL44219
Septipulmon
SFY
SMR000058213
Solfapiridina
Solfapiridina [DCIT]
SPBio_001445
SPBio_002743
Spectrum_000996
SPECTRUM1500551
Spectrum2_001323
Spectrum3_001773
Spectrum4_000346
Spectrum5_001182
SR-01000000207
SR-01000000207-2
ST45026614
STK292439
Streptosilpyridine
Sulfanilamide, N(sup 1)-2-pyridyl-
Sulfanilamide, N1-2-pyridyl-
Sulfanilamide, N1-2-pyridyl- (8CI)
Sulfanilamide, N1-2-pyridyl-(8CI)
Sulfanilamide, N1-2(1H)-pyridylidene-
Sulfapiridina
Sulfapiridina [INN-Spanish]
Sulfapyridin
Sulfapyridine (Dagenan)
Sulfapyridine (TN)
Sulfapyridine (USP/INN)
Sulfapyridine [USAN:INN:BAN]
Sulfapyridine [USP:INN:BAN]
Sulfapyridine melting point standard, pharmaceutical secondary standard; traceable to USP, Melting range approximately 191??C
Sulfapyridine Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sulfapyridine, >=99.0%
Sulfapyridine, European Pharmacopoeia (EP) Reference Standard
Sulfapyridine, United States Pharmacopeia (USP) Reference Standard
Sulfapyridine, VETRANAL(TM), analytical standard
Sulfapyridinum
Sulfapyridinum [INN-Latin]
Sulfidin
Sulfidine
Sulphapyridin
Sulphapyridine
Thioseptal
Tox21_110426
Tox21_110426_1
TR-005667
Trianon
UNII-Y5V2N1KE8U
UPCMLD0ENAT5889155:001
VZ28286
W-108148
WLN: T6NJ BMSWR DZ
Y5V2N1KE8U
Z271004858
ZB000484
ZINC2105

US Patents and Regulatory Information for SULFAPYRIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly SULFAPYRIDINE sulfapyridine TABLET;ORAL 000159-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Mallinckrodt
QuintilesIMS
Citi
Fuji
Cipla
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.